CSBR
Price
$7.68
Change
-$0.09 (-1.16%)
Updated
Jul 3, 02:00 PM (EDT)
Capitalization
107.57M
14 days until earnings call
MYNDF
Price
$0.03
Change
+$0.02 (+200.00%)
Updated
May 20 closing price
Capitalization
2.45M
Interact to see
Advertisement

CSBR vs MYNDF

Header iconCSBR vs MYNDF Comparison
Open Charts CSBR vs MYNDFBanner chart's image
Champions Oncology
Price$7.68
Change-$0.09 (-1.16%)
Volume$302
Capitalization107.57M
MYND Life Sciences
Price$0.03
Change+$0.02 (+200.00%)
Volume$200
Capitalization2.45M
CSBR vs MYNDF Comparison Chart in %
Loading...
CSBR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MYNDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CSBR vs. MYNDF commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSBR is a Hold and MYNDF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 04, 2025
Stock price -- (CSBR: $7.68 vs. MYNDF: $0.03)
Brand notoriety: CSBR and MYNDF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CSBR: 34% vs. MYNDF: 2%
Market capitalization -- CSBR: $107.57M vs. MYNDF: $2.45M
CSBR [@Biotechnology] is valued at $107.57M. MYNDF’s [@Biotechnology] market capitalization is $2.45M. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CSBR’s FA Score shows that 1 FA rating(s) are green whileMYNDF’s FA Score has 1 green FA rating(s).

  • CSBR’s FA Score: 1 green, 4 red.
  • MYNDF’s FA Score: 1 green, 4 red.
According to our system of comparison, both CSBR and MYNDF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CSBR’s TA Score shows that 3 TA indicator(s) are bullish while MYNDF’s TA Score has 2 bullish TA indicator(s).

  • CSBR’s TA Score: 3 bullish, 8 bearish.
  • MYNDF’s TA Score: 2 bullish, 1 bearish.
According to our system of comparison, MYNDF is a better buy in the short-term than CSBR.

Price Growth

CSBR (@Biotechnology) experienced а +6.37% price change this week, while MYNDF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

CSBR is expected to report earnings on Sep 10, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CSBR($108M) has a higher market cap than MYNDF($2.45M). CSBR YTD gains are higher at: -10.385 vs. MYNDF (-48.550). CSBR has higher annual earnings (EBITDA): 8.43M vs. MYNDF (-273.7K). CSBR has more cash in the bank: 3.2M vs. MYNDF (1.81K). MYNDF has less debt than CSBR: MYNDF (3M) vs CSBR (6.44M). CSBR has higher revenues than MYNDF: CSBR (58.6M) vs MYNDF (1).
CSBRMYNDFCSBR / MYNDF
Capitalization108M2.45M4,403%
EBITDA8.43M-273.7K-3,079%
Gain YTD-10.385-48.55021%
P/E Ratio17.07N/A-
Revenue58.6M15,860,000,000%
Total Cash3.2M1.81K177,200%
Total Debt6.44M3M215%
FUNDAMENTALS RATINGS
CSBR: Fundamental Ratings
CSBR
OUTLOOK RATING
1..100
20
VALUATION
overvalued / fair valued / undervalued
1..100
83
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
10
PRICE GROWTH RATING
1..100
48
P/E GROWTH RATING
1..100
78
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CSBRMYNDF
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
48%
Momentum
ODDS (%)
Bearish Trend 2 days ago
83%
N/A
MACD
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
35%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
55%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
54%
Advances
ODDS (%)
Bullish Trend 16 days ago
73%
N/A
Declines
ODDS (%)
Bearish Trend 3 days ago
79%
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
76%
Bullish Trend 2 days ago
71%
View a ticker or compare two or three
Interact to see
Advertisement
CSBR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MYNDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NN15.930.47
+3.04%
NextNav
STRR1.960.01
+0.51%
Star Equity Holdings Inc.
FNV165.090.65
+0.40%
Franco-Nevada Corp
HAYW14.20-0.14
-0.98%
Hayward Holdings
GAUZ7.49-0.32
-4.16%
Gauzy Ltd

CSBR and

Correlation & Price change

A.I.dvisor tells us that CSBR and SYRE have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CSBR and SYRE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CSBR
1D Price
Change %
CSBR100%
-1.16%
SYRE - CSBR
32%
Poorly correlated
+1.68%
SCNI - CSBR
27%
Poorly correlated
-2.95%
OABI - CSBR
25%
Poorly correlated
+3.76%
CVAC - CSBR
25%
Poorly correlated
+0.93%
MREO - CSBR
24%
Poorly correlated
N/A
More

MYNDF and

Correlation & Price change

A.I.dvisor tells us that MYNDF and NERV have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MYNDF and NERV's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MYNDF
1D Price
Change %
MYNDF100%
N/A
NERV - MYNDF
29%
Poorly correlated
-4.62%
ICCC - MYNDF
23%
Poorly correlated
+0.08%
CSBR - MYNDF
20%
Poorly correlated
-1.16%
AEON - MYNDF
7%
Poorly correlated
-0.29%
INKT - MYNDF
4%
Poorly correlated
+0.86%
More